ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,586.51
0.22%
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs Yen
155.782
-0.03%
Brent Oil
82.535
0.18%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. カナダ
  5. TSXV
  6. RepliCel Life Sciences Inc (RP)

  7. RepliCel Life Sciences Inc (RP) ニュース

RP

RepliCel Life Sciences (RP)

RepliCel Life Sciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:TSXV:RP
日付受信時刻ニュースソース見出しコード企業名
2024/05/0821 : 14PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - RPTSXV:RPRepliCel Life Sciences Inc
2024/05/0821 : 11PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - RPTSXV:RPRepliCel Life Sciences Inc
2023/11/2913 : 48PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:RPRepliCel Life Sciences Inc
2023/01/0511 : 04PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:RPRepliCel Life Sciences Inc
2019/12/2320 : 00PR Newswire (Canada)RepliCel Announces its Incoming Board of DirectorsTSXV:RPRepliCel Life Sciences Inc
2019/11/2620 : 00PR Newswire (Canada)RepliCel Provides 2019 Year-End UpdateTSXV:RPRepliCel Life Sciences Inc
2019/09/2419 : 00PR Newswire (Canada)Clinical Data Published from RepliCel's Skin Rejuvenation StudyTSXV:RPRepliCel Life Sciences Inc
2019/09/1019 : 00PR Newswire (Canada)RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in ChinaTSXV:RPRepliCel Life Sciences Inc
2019/08/2919 : 00PR Newswire (Canada)RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Auto...TSXV:RPRepliCel Life Sciences Inc
2019/04/1619 : 00PR Newswire (Canada)RepliCel Secures Several New Patents for its Regenerative Medicine TechnologiesTSXV:RPRepliCel Life Sciences Inc
2019/03/2619 : 00PR Newswire (Canada)RepliCel's Licensee Building Momentum in China with Facility and TeamTSXV:RPRepliCel Life Sciences Inc
2019/03/1919 : 00PR Newswire (Canada)RepliCel Reignites its First-in-Japan StrategyTSXV:RPRepliCel Life Sciences Inc
2019/03/0520 : 00PR Newswire (Canada)RepliCel CEO Provides 2019 Shareholder UpdateTSXV:RPRepliCel Life Sciences Inc
2018/11/0620 : 00PR Newswire (Canada)RepliCel Life Sciences Appoints Head of Clinical and Regulatory AffairsTSXV:RPRepliCel Life Sciences Inc
2018/10/1819 : 00PR Newswire (Canada)RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, CanadaTSXV:RPRepliCel Life Sciences Inc
2018/10/1719 : 00PR Newswire (Canada)RepliCel Life Sciences Appoints New Chief Financial OfficerTSXV:RPRepliCel Life Sciences Inc
2018/10/1519 : 00PR Newswire (Canada)RepliCel CEO Provides Updated OutlookTSXV:RPRepliCel Life Sciences Inc
2018/10/1119 : 00PR Newswire (Canada)RepliCel Life Sciences Completes Financing with YOFOTO (China) HealthTSXV:RPRepliCel Life Sciences Inc
2018/09/2419 : 00PR Newswire (Canada)RepliCel Life Sciences and YOFOTO (China) Health Obtain All Approvals Needed to Complete InvestmentTSXV:RPRepliCel Life Sciences Inc
2018/07/1119 : 00PR Newswire (Canada)RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater ChinaTSXV:RPRepliCel Life Sciences Inc
2018/05/0219 : 00PR Newswire (Canada)RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTOTSXV:RPRepliCel Life Sciences Inc
2018/01/2520 : 00PR Newswire (Canada)RepliCel CEO Provides 2018 Shareholder UpdateTSXV:RPRepliCel Life Sciences Inc
2018/01/1620 : 00PR Newswire (Canada)RepliCel Life Sciences Lands Commitment for Key Investment PartnershipTSXV:RPRepliCel Life Sciences Inc
2017/10/2006 : 00PR Newswire (Canada)RepliCel Life Sciences Successfully Closes FinancingTSXV:RPRepliCel Life Sciences Inc
2017/09/2309 : 24PR Newswire (Canada)RepliCel Retains Hybrid Financial for Investor RelationsTSXV:RPRepliCel Life Sciences Inc
2017/09/1319 : 00PR Newswire (Canada)RepliCel's Partnership Initiatives Mature into Licensing NegotiationsTSXV:RPRepliCel Life Sciences Inc
2017/09/0719 : 00PR Newswire (Canada)RepliCel Showcases First Fully-Functional Prototypes of its Next-Generation Dermal InjectorTSXV:RPRepliCel Life Sciences Inc
2017/08/1019 : 00PR Newswire (Canada)Prominent Skin Aging Researcher Provides Insights into RepliCel's Clinical DataTSXV:RPRepliCel Life Sciences Inc
2017/06/1319 : 00PR Newswire (Canada)RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell Data MapTSXV:RPRepliCel Life Sciences Inc
2017/05/2519 : 00PR Newswire (Canada)RepliCel CEO Provides Company OutlookTSXV:RPRepliCel Life Sciences Inc
 Showing the most relevant articles for your search:TSXV:RP

最近閲覧した銘柄

FX
USDGBP
US Dollar vs Sterling
NYSE
KO
Coca Cola
NYSE
AXP
American Express
NASDAQ
AMZN
Amazon.com
USOTC
ADDYY
Adidas (QX)
NASDAQ
GOOGL
Alphabet
NASDAQ
NVDA
NVIDIA
AMEX
SPY
SPDR S&P 500
AMEX
XLE
Energy Select Sector SPDR
FX
USDJPY
US Dollar vs Yen
CCOM
US500
US 500
NYSE
MCD
McDonalds
USOTC
BASFY
BASF (QX)
CCOM
SILVER
SILVER
FX
USDEUR
US Dollar vs Euro
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有